An algorithm to identify the development of lymphedema after breast cancer treatment.

Purpose: Large, population-based studies are needed to better understand lymphedema, a major source of morbidity among breast cancer survivors. One challenge is identifying lymphedema in a consistent fashion. We sought to develop and validate an algorithm using Medicare claims to identify lymphedema...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Cancer Survivorship Vol. 9; no. 2; pp. 161 - 172
Autores principales: Yen, Tina W F, Laud, Purushuttom W, Sparapani, Rodney A, Li, Jianing, Nattinger, Ann B
Formato: research Journal Article
Publicado: Springer Nature Jun2015
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=109738416&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 109738416
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        19322259
        46CU
      jtl: Journal of Cancer Survivorship
      issn: 19322259
      maglogo: N
    pubinfo:
      dt: Jun2015
      vid: 9
      iid: 2
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        109738416
        NLM25187004
        2013020527
        10.1007/s11764-014-0393-z
        NLM25187004
        PMC4362809
        109738416
      ppf: 161
      ppct: 11
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: An algorithm to identify the development of lymphedema after breast cancer treatment.
      aug:
        au:
          Yen, Tina W F
          Laud, Purushuttom W
          Sparapani, Rodney A
          Li, Jianing
          Nattinger, Ann B
      sug:
      ab: Purpose: Large, population-based studies are needed to better understand lymphedema, a major source of morbidity among breast cancer survivors. One challenge is identifying lymphedema in a consistent fashion. We sought to develop and validate an algorithm using Medicare claims to identify lymphedema after breast cancer surgery.Methods: From a population-based cohort of 2,597 elderly (65+) women who underwent incident breast cancer surgery in 2003 and completed annual telephone surveys through 2008, two algorithms were developed using Medicare claims from half of the cohort and validated in the remaining half. A lymphedema-positive case was defined by patient report.Results: A simple two ICD-9 code algorithm had 69 % sensitivity, 96 % specificity, positive predictive value >75 % if prevalence of lymphedema is >16 %, negative predictive value >90 %, and area under receiver operating characteristic curve (AUC) of 0.82 (95 % CI 0.80-0.85). A more sophisticated, multi-step algorithm utilizing diagnostic and treatment codes, logistic regression methods, and a reclassification step performed similarly to the two-code algorithm.Conclusions: Given the similar performance of the two validated algorithms, the ease of implementing the simple algorithm and the fact that the simple algorithm does not include treatment codes, we recommend that this two-code algorithm be validated in and applied to other population-based breast cancer cohorts.Implications For Cancer Survivors: This validated lymphedema algorithm will facilitate the conduct of large, population-based studies in key areas (incidence rates, risk factors, prevention measures, treatment, and cost/economic analyses) that are critical to advancing our understanding and management of this challenging and debilitating chronic disease.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N